David A. Siegel Sesen Bio, Inc. Transaction History

Two Sigma Advisers, LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.49 - $0.61 $11,074 - $13,786	22,600 New	22,600 $13,000
Q1 2022 May 16, 2022	SELL	$0.58 - $0.86 $204,847 - $303,739	-353,185 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.73 - $1.28 $1.4 Million - $2.45 Million	-1,916,933 Reduced 84.44%	353,185 $288,000
Q3 2021 Nov 15, 2021	SELL	$0.77 - $4.91 $382,074 - $2.44 Million	-496,200 Reduced 17.94%	2,270,118 $1.8 Million
Q2 2021 Aug 16, 2021	SELL	$2.18 - $4.66 $464,122 - $992,114	-212,900 Reduced 7.15%	2,766,318 $12.8 Million
Q1 2021 May 17, 2021	BUY	$1.3 - $3.24 $2.94 Million - $7.32 Million	2,260,200 Added 314.35%	2,979,218 $7.75 Million
Q4 2020 Feb 16, 2021	BUY	$1.01 - $1.77 $584,386 - $1.02 Million	578,600 Added 412.06%	719,018 $971,000
Q3 2020 Nov 16, 2020	BUY	$0.67 - $1.4 $63,047 - $131,740	94,100 Added 203.16%	140,418 $197,000
Q2 2020 Aug 14, 2020	BUY	$0.52 - $0.87 $5,460 - $9,135	10,500 Added 29.31%	46,318 $33,000
Q1 2020 May 15, 2020	BUY	$0.39 - $1.03 $3,423 - $9,041	8,778 Added 32.46%	35,818 $20,000
Q4 2019 Feb 14, 2020	BUY	$0.89 - $1.5 $24,065 - $40,560	27,040 New	27,040 $28,000
Q2 2019 Aug 14, 2019	SELL	$0.95 - $2.46 $10,009 - $25,918	-10,536 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$0.96 - $2.04 $17,088 - $36,312	-17,800 Reduced 62.82%	10,536 $15,000
Q3 2018 Nov 14, 2018	SELL	$1.54 - $2.38 $30,338 - $46,886	-19,700 Reduced 41.01%	28,336 $61,000
Q2 2018 Aug 14, 2018	BUY	$1.04 - $3.29 $49,957 - $158,038	48,036 New	48,036 $94,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.